FDA approves Regeneron's hearing loss gene therapy Otarmeni

April 23, 2026 02:53 PM EDTUpdated April 24, 06:46 AM PharmaCell/Gene TxFDA+ Up­dat­ed: Re­gen­eron snags hear­ing loss gene ther­a­py ap­proval, clos­es US pric­ing deal Lei Lei Wu News Reporter Max Bayer Senior Reporter Re­gen­eron has won the first-ever FDA ap­proval for a gene ther­a­py to treat a rare type of in­her­it­ed hear­ing loss, and the com­pa­ny plans to … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER